The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Sampath Anand since 2015.
This trader's CIK number is 1406493.
At the time of last reporting, Sampath Anand was the EVP, Ops & Clinical Research of Masimo Corp. (stock ticker symbol MASI).
Also see all insider trading activities at Masimo Corp.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | MASI | 0 | $0 | 0 | $0 | 2,000 | $0 |
| 2020 | MASI | 0 | $0 | 49,796 | $11,531,100 | 51,796 | $1,222,658 |
| 2019 | MASI | 0 | $0 | 75,000 | $10,046,550 | 77,000 | $1,965,150 |
| 2018 | MASI | 0 | $0 | 30,000 | $3,300,000 | 32,000 | $605,700 |
| 2017 | MASI | 0 | $0 | 40,000 | $3,680,000 | 50,000 | $1,237,000 |
| 2016 | MASI | 0 | $0 | 65,000 | $3,577,978 | 65,000 | $924,299 |
| 2015 | MASI | 0 | $0 | 45,000 | $1,890,000 | 45,000 | $510,075 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-01-02 | MASI | Option Ex | 2,000 | .00 | 0 |
| 2020-12-15 | MASI | Option Ex | 30,000 | 26.39 | 791,700 |
| 2020-12-15 | MASI | Sale | 30,000 | 265.59 | 7,967,820 |
| 2020-04-13 | MASI | Option Ex | 19,796 | 21.77 | 430,958 |
| 2020-04-13 | MASI | Sale | 19,796 | 180.00 | 3,563,280 |
| 2020-01-02 | MASI | Option Ex | 2,000 | .00 | 0 |
| 2019-11-20 | MASI | Sale | 15,000 | 155.00 | 2,325,000 |
| 2019-11-20 | MASI | Option Ex | 15,000 | 31.01 | 465,150 |
| 2019-06-14 | MASI | Sale | 30,000 | 142.38 | 4,271,550 |
| 2019-06-14 | MASI | Option Ex | 30,000 | 28.03 | 840,900 |
| 2019-01-15 | MASI | Option Ex | 30,000 | 21.97 | 659,100 |
| 2019-01-15 | MASI | Sale | 30,000 | 115.00 | 3,450,000 |
| 2019-01-02 | MASI | Option Ex | 2,000 | .00 | 0 |
| 2018-11-28 | MASI | Option Ex | 30,000 | 20.19 | 605,700 |
| 2018-11-28 | MASI | Sale | 30,000 | 110.00 | 3,300,000 |
| 2018-02-27 | MASI | Option Ex | 2,000 | .00 | 0 |
| 2017-07-11 | MASI | Option Ex | 40,000 | 27.37 | 1,094,800 |
| 2017-07-11 | MASI | Sale | 40,000 | 92.00 | 3,680,000 |
| 2017-01-12 | MASI | Option Ex | 10,000 | 14.22 | 142,200 |
| 2016-10-31 | MASI | Sale | 51,345 | 55.06 | 2,826,953 |
| 2016-11-01 | MASI | Sale | 13,655 | 55.00 | 751,025 |
| 2016-10-31 | MASI | Option Ex | 51,345 | 14.22 | 730,125 |
| 2016-11-01 | MASI | Option Ex | 13,655 | 14.22 | 194,174 |
| 2015-11-06 | MASI | Option Ex | 45,000 | 11.34 | 510,075 |
| 2015-11-06 | MASI | Sale | 45,000 | 42.00 | 1,890,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sampath Anand (EVP, Ops & Clinical Research of Masimo Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.